Research paperEffects of PANTETHINE (cas 138148-35-3) on in-vitro peroxidation of low density lipoproteins☆
-
Add time:08/23/2019 Source:sciencedirect.com
The effects of PANTETHINE (cas 138148-35-3) on LDL peroxidation in vitro are reported. LDL isolation by density gradient ultracentrifugation from 12 normal subjects were dialyzed 48 h under conditions allowing oxidation. The LDL peroxides were assayed for the presence of malondialdehyde (MDA) on the lipoprotein. The effect of peroxidation on the LDL protein moiety (apo B) was studied by SDS-gel electrophoresis. The presence in the dialysis buffer of 1 mM reduced glutathione or of an equimolar concentration of pantethine markedly inhibited the MDA formation in LDL. Less effective were 0.5 and 2 mM pantethine, while 10 mM pantethine did not prevent the LDL peroxidation. Both glutathione and pantethine (1 or 2 mM) preserved the original LDL electrophoretic mobility. The electronegative charge of LDL was correlated to the MDA production during the dialysis procedures. Freshly prepared LDL showed a single apo B band by SDS-gel electrophoresis (apo B-100). Following peroxidation 2 or 3 bands with higher molecular weight appeared. Both glutathione and pantethine (1 or 2 mM) strongly inhibited the appearance of higher molecular weight peptides. In appropriate concentrations therefore pantethine inhibits the LDL peroxidation in vitro, thus preserving the molecular integrity of apo B.
We also recommend Trading Suppliers and Manufacturers of PANTETHINE (cas 138148-35-3). Pls Click Website Link as below: cas 138148-35-3 suppliers
Prev:PANTETHINE (cas 138148-35-3), a somatostatin depleting agent, increases food intake in rats☆
Next:BBA reportModulation of HMG-CoA reductase activity by pantetheine/PANTETHINE (cas 138148-35-3)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- PANTETHINE (cas 138148-35-3) stimulates lipolysis in adipose tissue and inhibits cholesterol and fatty acid synthesis in liver and intestinal mucosa in the normolipidemic rat08/25/2019
- BBA reportModulation of HMG-CoA reductase activity by pantetheine/PANTETHINE (cas 138148-35-3)08/24/2019
- PANTETHINE (cas 138148-35-3), a somatostatin depleting agent, increases food intake in rats☆08/22/2019
- Research paperPANTETHINE (cas 138148-35-3) lipomodulation: evidence for cysteamine mediation in vitro and in vivo08/21/2019
- Reduction of PANTETHINE (cas 138148-35-3) in rabbit ocular lens homogenate08/20/2019
- Review articleTreatment of hyperlipoproteinemia with PANTETHINE (cas 138148-35-3): A review and analysis of efficacy and tolerability08/19/2019
- Original ArticleEfficacy and tolerability of coenzyme A vs PANTETHINE (cas 138148-35-3) for the treatment of patients with hyperlipidemia: A randomized, double-blind, multicenter study08/18/2019
- Original articleComparison of the effects of PANTETHINE (cas 138148-35-3) and fursultiamine on plasma levels of adrenocorticotropic hormone and neuropeptide Y under continual stress exposure08/17/2019


